Merck represents a strong commitment to its core values and corporate philosophy. With over a century of experience, the company prioritizes innovation, integrity, and excellence. By focusing on scientific advancements, Merck strives to make a positive impact on global healthcare. Its dedication to ethical business practices ensures transparency, trust, and accountability. Merck emphasizes collaboration and teamwork, fostering a culture that encourages diverse perspectives and inclusivity. As a leading pharmaceutical company, Merck continually seeks to improve the well-being of individuals and communities worldwide through its mission of advancing science and healthcare.

Merck is primarily present in various countries and regions worldwide. The company has a strong global presence and operates in multiple key markets. Some of the primary regions where Merck operates include North America, Europe, Asia-Pacific, Latin America, and the Middle East. Merck's diverse international presence enables it to serve a wide range of customers and expand its reach in both developed and emerging markets.

Merck, a global pharmaceutical company, has achieved several significant milestones throughout its history. One notable achievement is the discovery of groundbreaking medicines and vaccines in various therapeutic areas. Additionally, Merck has garnered accolades for its research and development efforts, advancing medical science and improving patient outcomes. The company has also played a crucial role in public health initiatives, such as developing treatments for HIV/AIDS and providing affordable access to essential medications. With a commitment to innovation and scientific excellence, Merck continues to make strides in addressing unmet medical needs and improving global healthcare.

Merck, a global pharmaceutical company, has a rich history and background. Established in 1668, Merck has been dedicated to improving human health for over 350 years. With its headquarters in Darmstadt, Germany, the company has evolved into a leading scientific research and development organization, focusing on innovative medicines, vaccines, and healthcare solutions. Merck has a strong global presence, operating in more than 140 countries. Over the years, it has expanded its portfolio to address a wide range of diseases and conditions, including cancer, infectious diseases, cardiovascular disorders, and more. Merck remains committed to innovation, scientific excellence, and improving the lives of patients worldwide.

The main competitors of Merck in the market include pharmaceutical companies such as Pfizer, Johnson & Johnson, Novartis, and GlaxoSmithKline. These companies operate in the same industry and offer similar products and services, competing for market share and innovation. Although each company has its own unique strengths and areas of focus, Merck faces intense competition in the global pharmaceutical market from these key players.

Merck is primarily active in the pharmaceutical and life sciences industries. As a global healthcare company, Merck focuses on discovering, developing, manufacturing, and marketing innovative medicines, vaccines, and animal health products. With a strong emphasis on research and development, Merck operates in various therapeutic areas such as oncology, immunology, cardiovascular diseases, infectious diseases, and neurology. The company's commitment to advancing healthcare solutions and improving patient outcomes has made it a leader in the industry. Merck's portfolio encompasses a wide range of prescription drugs, over-the-counter products, and biologic therapies, serving millions of people worldwide.

The business model of Merck is centered around the development, manufacturing, and sale of pharmaceutical, healthcare, and life science products. As a leading global healthcare company, Merck focuses on research and innovation to provide innovative and high-quality solutions for patients and healthcare professionals. Through its diverse portfolio of prescription medicines, vaccines, biologic therapies, and animal health products, Merck aims to improve health outcomes worldwide. With a strong emphasis on scientific advancements and a commitment to delivering value, Merck strives to address unmet medical needs and contribute to the well-being of individuals and communities across the globe.

Pašreizējais KGV Merck KGaA nevar tikt aprēķināts.

KUV šobrīd Merck KGaA nevar aprēķināt.

AlleAktien kvalitātes vērtējums Merck KGaA ir 7/10.

Pašreiz nevar aprēķināt apgrozījumu Merck KGaA.

Pašlaik peļņa Merck KGaA nevar tikt aprēķināta.

The Merck Group is a global company active in various sectors of the chemical, pharmaceutical, and biotechnology industries. The company's strategy is based on three pillars: innovation, expertise, and internationality. The pharmaceutical sector of the company specializes in the development, production, and marketing of prescription drugs. Merck offers both patented medications and innovative biological treatment options in this area. These include medications for cancer, multiple sclerosis, as well as a variety of pain relievers and anti-inflammatory drugs. In addition to the development of prescription drugs, Merck also has a division for the production of over-the-counter medications and dietary supplements. Another important division of Merck is the Life Science division. This includes the development and production of laboratory technologies, biopharmaceuticals, and research instruments. This includes, for example, cell culture systems or high-tech laboratory equipment for protein expression analysis. Merck's Life Science division is a leader in biotechnology and offers research solutions for industry and science. Furthermore, Merck is also active in the Performance Materials business unit. Here, the company produces, among other things, liquid crystals, organic light-emitting diodes (OLEDs), or high-tech materials for the semiconductor industry. Merck's Performance Materials division is considered the world's leading provider of high-tech materials. Another pillar of Merck is its Consumer Health products. This includes the production and marketing of over-the-counter medications for self-medication, which are available in pharmacies and drugstores. These include, for example, pain relievers, cough and cold remedies, or dietary supplements. Merck's Consumer Health products are distributed worldwide and have a high level of awareness. Merck's business model is designed for long-term success and stable growth. Innovation and collaboration with experts and partners are of great importance. Merck focuses on strong international orientation and the exploration of new markets. The company also engages with society and advocates for sustainable development. In summary, Merck offers innovative and high-quality products and services in the areas of pharmaceuticals, Life Science, Performance Materials, and Consumer Health. The company's expertise lies in the development of new technologies and biotechnological processes. The goal of the company is to serve existing markets but also to explore new ones in order to achieve long-term growth.

Merck KGaA izmaksā dividendes 0 EUR, kas tiek izmaksātas 1 reizes gadā.

Merck KGaA izmaksā dividendes 1 reizes gadā.

Merck KGaA ISIN ir DE0006599905.

Merck KGaA WKN ir 659990.

Merck KGaA simbols ir MRK.DE.

Pēdējo 12 mēnešu laikā Merck KGaA maksāja dividendes apmērā. Tas atbilst aptuveni dividendes ražībai. Nākamajos 12 mēnešos Merck KGaA plāno maksāt dividendes 2,42 EUR apmērā.

Merck KGaA pašreizējā dividendu rentabilitāte ir .

Merck KGaA maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos maijs, maijs, jūnijs, maijs.

Merck KGaA pēdējo 26 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 2,42 EUR. Tas atbilst dividendes ražībai 1,75 %.

Merck KGaA tiek piešķirts nozarei "Veselība".

Lai saņemtu pēdējo dividendu Merck KGaA apmērā 2,2 EUR, kas tika izmaksāta 2.05.2024., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 29.04.2024..

Pēdējās dividendes izmaksa notika 2.05.2024..

Gadā 2023, Merck KGaA izmaksāja 1,85 EUR dividendes.

Merck KGaA dividendes tiek izmaksātas EUR.